Full Info:

Resource Type:

Journal Article

Citation:

Unintended pregnancy and unmet need for modern contraception contribute substantially to reproductive health disparities globally. In sub-Saharan Africa they occur in contexts of disproportionately high rates of HIV infection. Multipurpose prevention technologies (MPTs) can address HIV and pregnancy prevention needs in a single “2-in-1” product; however, few studies have solicited end-user views to inform design of new MPTs. We conducted the Tablets, Ring, Injections as Options (TRIO) study with young women aged 18−30 in Kenya and South Africa (N = 277) to examine preferences and acceptability of future MPTs. End-user research to identify and pre-emptively address potential barriers while underscoring benefits to a new MPT product is vital. Attention to cultural contexts in implementation of new MPTs is important to communicating perceived benefits, achieving acceptability and maximising public health benefits.

Authors:

Minnis, A.; Krogstad, E.; Shapley-Quinn, M.K.; Agot, K.; Ahmed, K.; & Wagner, L.D.

Health Risks(s):

• HIV
• STI / STD
• Unintended Pregnancy

Product type(s):

• ARVs
• Condoms
• Contraceptives
• Hormonal
• Injectables
• IVR
• MPTs

Topic(s):

• MPTs
• Product Introduction
• Reproductive Health
• Social
• SRH

Region(s)

• Africa
• Global